Purpose

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Perinatal HIV infection as documented in the medical record; - At or beyond their 18th birthday at the time of informed consent with no upper age limit; - Willingness to provide access to existing medical records; and - Willingness to participate and provide legal consent

Exclusion Criteria

  • Prisoner status

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Infected Cohort Perinatally HIV-infected participants at or beyond their 18th birthday at enrollment.

Recruiting Locations

Boston Medical Center
Boston, Massachusetts 02118
Contact:
Debra McLaud, RN
617-414-5813
debra.mclaud@bmc.org

More Details

Status
Recruiting
Sponsor
Harvard School of Public Health

Study Contact

Liz Salomon, EdM
6174324567
lsalomon@hsph.harvard.edu

Detailed Description

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: 1. To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune suppression, viral resistance, end-organ disease, and mortality. 2. To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults with perinatal HIV. 3. To define the impact of perinatal HIV infection and ART on long-term mental and behavioral health outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.